Results
139
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
139 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TRAN A | SEK 1.87 | 3.6% | -19.6% | SEK 182.1m | n/a | PE5.2x | n/a | 22.5% | Diversified Financials | ||
ANGL | SEK 4.58 | 0.4% | 21.0% | SEK 343.4m | SEK 7.67 | PE12.2x | E26.8% | 0% | Consumer Services | ||
KONT | SEK 2.26 | -13.1% | -13.1% | SEK 72.4m | SEK 5.20 | PE93.5x | E82.0% | n/a | Healthcare | ||
NEWBRY | SEK 3.40 | 0% | -24.6% | SEK 82.5m | SEK 8.00 | PS2.6x | E146.2% | n/a | Pharmaceuticals & Biotech | ||
ACE | SEK 2.86 | 0% | -68.9% | SEK 274.9m | SEK 8.25 | PB2.6x | E47.2% | n/a | Pharmaceuticals & Biotech | ||
NITRO | SEK 2.74 | 6.2% | -43.8% | SEK 68.3m | SEK 5.01 | PE7.2x | E53.1% | n/a | Media | ||
LPGO | SEK 0.14 | -20.9% | -68.8% | SEK 20.7m | SEK 0.90 | PS2.3x | E139.5% | n/a | Pharmaceuticals & Biotech | ||
FREEM | SEK 0.88 | -17.8% | -85.8% | SEK 60.5m | SEK 4.23 | PS1.1x | E54.8% | n/a | Capital Goods | ||
ENRO | SEK 0.49 | -0.8% | -17.3% | SEK 355.3m | n/a | PE7.3x | n/a | 8.2% | Media | ||
KAN | SEK 1.03 | -1.3% | -75.0% | SEK 125.3m | SEK 3.10 | PB1.7x | E48.3% | n/a | Pharmaceuticals & Biotech | ||
ICO | SEK 4.41 | -5.2% | -49.8% | SEK 93.6m | SEK 16.75 | PS3.7x | S68.6% | n/a | Healthcare | ||
SPAGO | SEK 0.27 | 1.5% | -18.8% | SEK 93.3m | SEK 0.80 | PS13.4x | E119.8% | n/a | Pharmaceuticals & Biotech | ||
KLAR | SEK 1.13 | 14.1% | 121.6% | SEK 163.6m | SEK 1.20 | PB12.7x | E93.9% | n/a | Pharmaceuticals & Biotech | ||
FRILAN | SEK 4.94 | 6.0% | 29.7% | SEK 143.5m | n/a | PE12.5x | n/a | 2.0% | Diversified Financials | ||
META | SEK 0.089 | -3.0% | -75.4% | SEK 61.3m | SEK 0.12 | PS2.5x | E43.0% | n/a | Capital Goods | ||
ELIC | SEK 3.33 | 0.3% | 86.6% | SEK 116.9m | SEK 3.80 | PS16.4x | S118.4% | n/a | Pharmaceuticals & Biotech | ||
AROC | SEK 0.55 | -6.8% | 34.9% | SEK 125.5m | SEK 0.90 | PS2.4x | E25.6% | n/a | Pharmaceuticals & Biotech | ||
ACCON | SEK 4.66 | -0.4% | -40.8% | SEK 289.6m | SEK 8.00 | PS5.6x | E80.8% | n/a | Tech | ||
NXTCL | SEK 3.30 | 14.6% | 29.4% | SEK 241.2m | SEK 8.00 | PS25.5x | S116.8% | n/a | Pharmaceuticals & Biotech | ||
NBZ | SEK 0.20 | -1.9% | -48.2% | SEK 49.4m | SEK 0.75 | PS0.3x | S43.2% | n/a | Consumer Durables | ||
HIFA B | SEK 3.34 | 4.4% | 31.5% | SEK 203.2m | n/a | PE9.9x | n/a | 0% | Commercial Services | ||
MERIS | SEK 0.59 | -14.4% | 13.3% | SEK 515.7m | SEK 0.47 | PS0.6x | E82.8% | n/a | Capital Goods | ||
CLS B | SEK 3.98 | -1.0% | -81.9% | SEK 80.3m | SEK 14.00 | PS4.3x | E63.8% | n/a | Healthcare | ||
ACARIX | SEK 0.24 | 6.4% | -30.0% | SEK 254.8m | SEK 0.45 | PS44.9x | E110.4% | n/a | Healthcare |